Research output per year
Research output per year
The University of Western Australia (M704), 35 Stirling Highway,
6009 Perth
Australia
Medical degree (MBBS) St Mary’s Hospital, London 1994; Basic Surgical Training in London (FRCS (Eng) 1998). Research Fellow University College London - doctorate in medicine (MD) 2003. Specialist Training West Midlands, UK (FRCS Urol) 2006. FRACS 2011
Professor Dickon Hayne is a clinical academic who leads urological research and education in urology, at the University of Western Australia. He works as consultant urological surgeon and is the Head of Urology for the South Metropolitan Health Service, WA. He is Chair of the Bladder, Urothelial and Penile (BUP) Cancer Sub-committee of the Australian & New Zealand Urogenital & Prostate Cancer Trials Group (ANZUP), an SAC member, leads the BCGMM trial and is widely engaged in other sub-committees, trials and activities of ANZUP. His major clinical and research interests are urological cancer, in particular bladder cancer.
Sequential BCG and mitomycin intra-vesical therapy versus BCG alone for high-risk non-muscle invasive bladder cancer (NMIBC): 2 stage randomized phase III trial. Accrual complete (n=501) in follow up.
Sub-urothelial injection of immune therapeutic agents - SUBDUE-1 completed in write up. SUBDUE -2 deferred. SUBDUE-3 in development
RESEARCH GRANTS AND FUNDING
June 2022 Valar Labs
Identification of BCG Unresponsive NMIBC
Small grant (8k) for initial collaborration
April 2022 WACPCN Special Grants
Addressing Inequalities Facing West Australians with Bladder Cancer
$44896.29 Project supervisor
Octber 2021 ANZUP 'Below the Belt'
Exploratory Translational work for BCGMM trial
$50000
October 2021 WACPCN Cancer Fellowship
Shifting the Curve - Translating Contemporary Trials for Improved Bladder Cancer Survival
TRanslational work for BCGMM and SUBDUE trials
Approx value $200000 Co-supervisor
May 2021 Telix Pharmaceuticals unrestricted II grant for ZipUp Trial
$110000
December 2020 Cancer Council WA
Telex trial - RCT telehealth vs clinic based weight loss program for overweight prostate cancer pts
$472739 (CIA Prof D Galvao CID Prof D Hayne)
November 2019 Spinnaker Health Research Foundation
SUBDUE-1 Translational work
$15000
July 2019 ANZUP ‘Below the Belt Research Fund’
SUBDUE-1 SUB-urothelial DUrvalumab InjEction – 1
$50000
Dickon Hayne and Andrew Moe
July 2019 WACPCN Special Grants
OPTIMAL CARE PATHWAYS – Implementation grant Robotic Surgery
$80000
Dec 2018 NHMRC
BCG+MM Trial: Adding mitomycin to BCG as adjuvant intravesical therapy for high-risk, non–muscle-invasive bladder cancer: a 2-stage, randomised phase 3 trial
5 year funding $1,587,163.80 until 2023 (Funds to complete trial)
CIA Professor Dickon Hayne
Nov 2017 NHMRC
Can Exercise Delay Transition to Active Therapy in Men with Low Grade Prostate Cancer? A Multi-Centre Randomized Controlled Trial
5 year funding $596,083.90 until Dec 2022
CIA Daniel Galvao (ECU)
CIE Professor Dickon Hayne
July 2017 ANZUP ‘Below the Belt Research Fund’
‘ANZUP co-operative multi-centre cystectomy database’
$50000
Sole recipient
July 2017 ANZUP ‘Below the Belt Research Fund’
‘Exercise Medicine Prior to Open Radical Cystectomy: Feasibility and Preliminary Efficacy’
$50000
Dennis Taafe and Dickon Hayne
December 2015 Cancer Australia (Nationally Competitive via NHMRC)
Developing a patient-reported symptom index for non-muscle invasive bladder cancer
$466,317, start date 30 June 2016
CIA Associate Professor Manish Patel
CIC Professor Dickon Hayne
June 2015 WACPCN Special Grants
Project title: Advancing Cystectomy Care: an Enhanced recovery Pathway Trial (ACCEPT)
$18,000 for one year –seeding funding
Dr Dwayne Chan and Professor Dickon Hayne
Jan 2015 University of Sydney Bridging Support Grant 2015
NHMRC Project Grant: APP1080786: OPTIMUM: Optimising Perioperative Therapy in Muscle invasive Urothelial Malignancy. A phase 3 trial of cisplatin and gemcitabine (CG) vs accelerated MVAC (accMVAC) given before or after cystectomy
$30,000 for 1 year
CIA Professor Martin Stockler
CIB Professor Ian Davis
CIC Professor Dickon Hayne
CID Associate Professor Shomik Sengupta
CIE Professor Howard Gurney
CIF Dr Andrew Martin
CIG Dr Sonia Yip
Nov 2014 Cancer Australia (Nationally Competitive via NHMRC)
A phase 3, double-blind, placebo-controlled, randomised trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal, ultrasound-guided prostate biopsy
$597,095 for 3 yrs
CIA Professor Ian Davis
CIB Dr Jeremy Grummet
CIC Dr Venu Chalasani
CID Professor Martin Stockler
CIE Dr Andrew Martin
CIF Professor Dickon Hayne
CIG Henry Woo
CIH Mark Frydenberg
CII Colin O’Brien
Sept 2013 Cancer and Palliative Care Research and Evaluation Unit (CAPREU)
Delays in presentation to the 'One Stop Haematuria Clinic' at Fremantle Hospital: a study of reasons for delay, and introduction of strategies to combat the only cancer in Australia with deteriorating survival',
$20000 for 12 months
Dr Steve McCombie and Professor Dickon Hayne
Jan 2013 Cancer Australia (Nationally Competitive via NHMRC)
Adding MMC to BCG for high-risk non-muscle invasive bladder cancer: a randomised phase 3 trial
$457,143.17 for 3 years commencing 2013
Administering Institution University of Sydney
CIA Professor Dickon Hayne
CIB Associate Professor Manish Patel
CIC Associate Professor Martin Stockler
CID Associate Professor Damien Bolton
CIE Associate Professor Mark Frydenberg
CIF Doctor Venu Chalasani
CIG Mr Mark Chatfield
CIH Miss Amy Boland
CII Professor Ian Davis
CIJ Mr Shomik Sengupta
Nov 2012 Fremantle Hospital Research Foundation
‘Penile Cancer in WA’
$15000 for 1 year
Dr Kevin McMillan
Professor Lyn Fritschi,
Dr David Sofield,
Ms Cynthia Hawks,
Professor Dickon Hayne (Project Lead)
Nov 2012 Cancer and Palliative Care Research and Evaluation Unit (CAPREU)
Investigation to determine evidence of bladder cancer stage migration as recorded by the WA Cancer Registry for the periods (1982-1986), (2000-2004) and (2007-2011
$17 500 for 1 year
Prof. Dickon Hayne (PI)
Prof. Lyn Fritschi,
Dr Callum Logan,
Cynthia Hawks
Nov 2010 NHMRC
PROCARE trial -A phase II trial of follow-up of men with prostate cancer in primary care
$564410.4 for 3 years
Administering institution: University of Western Australia
CIA: Prof Jon Emery
CIB: A/Prof Penelope Schofield
CIC: A/Prof Michael Jefford
CID: Prof Madeleine Kin,
CIE: Dr Marie Pirotta
CIF: Prof Dickon Hayne
CIG: Dr Andrew Martin
CIH: A/Prof Lyndal Trevena
Oct 2010 Prostate Cancer Foundation of Australia
Clinical Equipment Grant for bone densitometer
$80000
Professor Robert U. Newton,
Professor Daniel Galvão,
Professor Nigel Spry,
Professor David Joseph,
Dr Richard Prince,
Professor Dickon Hayne,
Dr Prue Cormie
July 2009 UWA Faculty Teaching and Learning Committee
General Surgery Web based Learning Modules
$6000 for 1 year
Professor Dickon Hayne (Project Lead)
Mr Khaled Dawas (University College London)
Associate Professor Diana Jonas-Dwyer (Medical Education)
Ms Fiona Leece (Project Officer E-Learning)
Nov 2008 UWA Faculty of Medicine, Dentistry and Health Sciences
Seeding Funding
$20000 for 3 years
Professor Dickon Hayne
July 2008 Faculty Teaching and Learning Committee
Urology Web Based Learning Modules
Professor Dickon Hayne (Project Lead)
Dr Wei Ling Ooi
Associate Professor Diana Jonas-Dwyer
Ms Fiona Leece
$5000 for 1 year
Mar 2008 WA Cancer & Palliative Care Network
‘One Stop Haematuria Clinic’ Clinical equipment grant / seeding funding
$30000
Prof. Dickon Hayne
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research output: Contribution to journal › Review article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Hayne, D. (Investigator 01)
1/06/22 → 1/06/23
Project: Research
McCombie, S. (Investigator 01), Hayne, D. (Investigator 02), Redfern, A. (Investigator 03), Spalding, L. (Investigator 04), Swarbrick, N. (Investigator 05) & Law, N. (Investigator 06)
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
15/10/21 → 15/10/23
Project: Research
Hayne, D. (Investigator 01)
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
1/07/19 → 30/06/21
Project: Research
Hayne, D. (Investigator 01)
Department of Health (Western Australia)
14/06/19 → 23/04/21
Project: Research
Hayne, D. (Investigator 01), Stockler, M. (Investigator 02), Davis, I. (Investigator 03), Frydenberg, M. (Investigator 04), Martin, A. (Investigator 05), Patel, M. (Investigator 06), Grummet, J. (Investigator 07), Krieger, L. (Investigator 08), Lawrence, N. (Investigator 09) & Sengupta, S. (Investigator 10)
NHMRC National Health and Medical Research Council
1/01/18 → 1/01/23
Project: Research
Hayne, D. (Recipient), 14 Nov 2023
Prize: Other distinction
19/03/24
1 Media contribution
Press/Media: Press / Media
19/03/24
1 Media contribution
Press/Media: Press / Media
19/03/24
1 Media contribution
Press/Media: Press / Media
1/07/23
1 Media contribution
Press/Media: Press / Media